High-risk Medulloblastoma-Balancing the High Stakes of Molecular Profiling to Enhance Treatment Responsivity

JAMA Oncol. 2021 Sep 1;7(9):1322-1323. doi: 10.1001/jamaoncol.2021.2084.

Authors

Allison M Martin¹, Sadhana Jackson^{2

3}

Affiliations

¹ Department of Pediatrics, Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York.
² Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland.
³ Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.

PMID: 34292302
DOI: 10.1001/jamaoncol.2021.2084

No abstract available

Publication types

Comment

MeSH terms

Biomarkers, Tumor / genetics
Cerebellar Neoplasms* / genetics
Cerebellar Neoplasms* / therapy
Gene Expression Profiling
Humans
Medulloblastoma* / drug therapy
Medulloblastoma* / genetics

Substances

Biomarkers, Tumor